
Sanofi's Dr Jack Prior detailed a data maturity framework for biologics manufacturing, while FDA and Gilead panelists debated risk-based AI validation.
Jack Prior is Head, Global Manufacturing Science and Technology at Sanofi.

Sanofi's Dr Jack Prior detailed a data maturity framework for biologics manufacturing, while FDA and Gilead panelists debated risk-based AI validation.

The authors present a robust and easy-to-implement chromatography column performance assessment method, called direct transition analysis (DTA).

January 1st 2018